PointsBet shares dipped 15% after the company cut its full-year revenue and earnings guidance. Here's what management had to ...
ResMed (ASX: RMD) posted a solid December quarter, with most figures slightly exceeding market expectations, driven by strong ...
After the result, Barrenjoey upgraded their target price by 18% to $3.30.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback